Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
14.92
-0.20 (-1.32%)
At close: May 12, 2025, 4:00 PM
15.00
+0.08 (0.54%)
After-hours: May 12, 2025, 5:09 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Alignment Healthcare stock have an average target of 17.45, with a low estimate of 9.00 and a high estimate of 23. The average target predicts an increase of 16.96% from the current stock price of 14.92.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 9 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +13.94% | May 2, 2025 |
| Baird | Baird | Buy Maintains $17 → $22 | Buy | Maintains | $17 → $22 | +47.45% | Apr 15, 2025 |
| Stifel | Stifel | Strong Buy Maintains $18 → $23 | Strong Buy | Maintains | $18 → $23 | +54.16% | Apr 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | +13.94% | Mar 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $21 | Buy | Maintains | $14 → $21 | +40.75% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
3.87B
from 2.70B
Increased by 42.96%
Revenue Next Year
4.83B
from 3.87B
Increased by 24.86%
EPS This Year
-0.40
from -0.67
EPS Next Year
-0.21
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.0B | 5.2B | 5.4B | ||
| Avg | 3.9B | 4.8B | 5.2B | ||
| Low | 3.7B | 4.4B | 4.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.5% | 34.4% | 11.9% | ||
| Avg | 43.0% | 24.9% | 7.2% | ||
| Low | 35.8% | 14.6% | 1.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.29 | -0.04 | 0.15 | ||
| Avg | -0.40 | -0.21 | -0.06 | ||
| Low | -0.53 | -0.46 | -0.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.